You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
產業聯合丨貝康醫療集團(2170.HK)與菁華醫療集團舉行“集團戰略攜手”簽約儀式
格隆匯 12-24 18:17
貝康醫療集團(2170.HK)今日與菁華醫療集團在瀋陽舉行戰略合作簽約儀式。貝康醫療擁有涵蓋男科、胚胎培養、遺傳學等全產業鏈的技術平台,提供全球領先的技術支持,旨在推動菁華醫療在科研和學科建設上的提升。菁華醫療作為東北首家試管嬰兒醫院,是全國排名前十的輔助生殖醫療集團,年生殖週期超過13000例。此次合作,貝康醫療將通過其完整的產業鏈服務支持菁華醫療,打造國際化的示範中心,並推動其成為全球領先的優生高地。此次合作核心目標包括兩個方向:首先,貝康旗下Geri全時差培養箱是全球首個可加濕的全時差培養箱,並通過超十萬例臨牀胚胎檢測驗證,研究顯示臨牀妊娠率可提高15%,活產率提高5.8%。貝康醫療將在此基礎上幫助菁華醫療建設國際一流的胚胎實驗室,提升臨牀治療效果。其次,貝康醫療將推動遺傳學科發展,為菁華醫療提供定製化遺傳實驗室建設方案。貝康醫療在胚胎植入前遺傳學篩查領域處於行業領先地位,發表學術論文百餘篇,參與起草了PGT-A檢測試劑的質量控制技術評價指南,並參加制定了國家PGT-A檢測試劑盒行業標準,尤其是其PGT-Plus一體化檢測技術,能夠檢測三倍體、單倍體等複雜遺傳問題。此次合作將助力菁華醫療為患者提供精準的遺傳諮詢與診療服務,推動遺傳學科在輔助生殖中的廣泛應用。貝康醫療的“全產業鏈賦能計劃”將在2025年全面實施,進一步深化與菁華醫療的合作,推動集團直銷模式,優化供應鏈管理,助力菁華醫療成為全球領先的智能化輔助生殖示範中心。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account